CTYPE html> BacVacDB | Bacterial Diseases

Browse By Bacterial Diseases

This page shows data for Meningococcal disease disease.
Total Entries Retrieved: 20
IDName of the vaccineDisease nameName of bacteriaType of vaccineName of the manufacturerClinical Phase statusRoute of administrationPubMed identifierClinical trial number
1123 MENVEO Meningococcal disease Neisseria meningitidis Inactivated GSK Vaccines Approved Intramuscular NA NA
1124 Menactra Meningococcal disease Neisseria meningitidis Inactivated Sanofi Pasteur Inc. Approved Intramuscular NA NA
1125 Bexsero Meningococcal disease Neisseria meningitidis Recombinant GSK Vaccines Approved Intramuscular NA NA
1126 Bexsero (In UK) Meningococcal disease Neisseria meningitidis Recombinant GSK Vaccines Approved Intramuscular NA NA
1127 TRUMENBA Meningococcal disease Neisseria meningitidis Recombinant Pfizer (Wyeth Pharmaceuticals) Approved Intramuscular NA NA
1128 MenQuadfi Meningococcal disease Neisseria meningitidis Conjugate Sanofi Pasteur Inc. Approved Intramuscular NA NA
1129 Menomune Meningococcal disease Neisseria meningitidis Polysaccharide Sanofi Pasteur Inc. Approved Subcutaneous NA NA
1130 MenHibrix Meningococcal disease Neisseria meningitidis Conjugate GlaxoSmithKline Biologicals Approved Intramuscular NA NA
1131 Menitorix Meningococcal disease Neisseria meningitidis Conjugate GlaxoSmithKline Biologicals Approved Intramuscular NA NA
1132 Nimenrix Meningococcal disease Neisseria meningitidis Conjugate Pfizer Approved Intramuscular NA NA
1133 Menjugate Meningococcal disease Neisseria meningitidis Conjugate GSK Vaccines S.r.l. Approved Intramuscular NA NA
1134 Meningitec Meningococcal disease Neisseria meningitidis Conjugate Wyeth Pharmaceuticals Approved Intramuscular 12675020 NA
1135 Mencevax ACWY Meningococcal disease Neisseria meningitidis Subunit GlaxoSmithKline Biologicals Approved Subcutaneous NA NA
1136 Quadri Meningo Meningococcal disease Neisseria meningitidis Polysaccharide Biomed Labs Approved Subcutaneous NA NA
1137 NEISVAC-C Meningococcal disease Neisseria meningitidis Conjugate Pfizer Approved Intramuscular NA NA
1337 Meningo A+C Meningococcal disease Neisseria meningitidis Polysaccharide Sanofi Pasteur, a Sanofi Company Clinical - Phase 4 Subcutaneous NA NCT01430611
1338 Meng Ling Kang Meningococcal disease Neisseria meningitidis Polysaccharide Sanofi Pasteur, a Sanofi Company Clinical - Phase 4 Subcutaneous NA NCT01430611
1339 Walvax MPV ACYW Meningococcal disease Neisseria meningitidis Polysaccharide Walvax Biotechnology Co., Ltd. Clinical - Phase 4 Intramuscular NA NCT04450498
1340 NmCV-5 Meningococcal disease Neisseria meningitidis Conjugate Serum Institute of India Pvt. Ltd. Clinical - Phase 3 Intramuscular NA NCT03964012
1341 MenCC-BIO Meningococcal disease Neisseria meningitidis Conjugate The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) Clinical - Phase 2, Phase 3 NA NA NCT02858570